Ms. Myers will participate on a panel addressing trends in drug approvals. She will join moderator Michael S. Labson, Partner, Covington & Burling and fellow panelist Klara A. Dickinson, Senior Vice President, Regulatory Affairs and Compliance, Hyperion Therapeutics, on the panel, entitled “New Drug Approval at FDA: Is it Really as Bad as You Think It is?” Biotech Showcase is taking place Jan. 10-12 in San Francisco. For further information:
Link to conference program: